Tag: mrna

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 19 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.00 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 19 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.00 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 19 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.00 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 19 articles (1.0x avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.00 |
    IV Percentile: 0% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18